Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2269974
Max Phase: Preclinical
Molecular Formula: C21H29N3O4
Molecular Weight: 387.48
Molecule Type: Small molecule
Associated Items:
ID: ALA2269974
Max Phase: Preclinical
Molecular Formula: C21H29N3O4
Molecular Weight: 387.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOCCc1ccc(OCCN(C(C)=O)C(=O)c2cc(C)nn2C)c(C)c1
Standard InChI: InChI=1S/C21H29N3O4/c1-6-27-11-9-18-7-8-20(15(2)13-18)28-12-10-24(17(4)25)21(26)19-14-16(3)22-23(19)5/h7-8,13-14H,6,9-12H2,1-5H3
Standard InChI Key: UBCSCBHQEPFISF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 387.48 | Molecular Weight (Monoisotopic): 387.2158 | AlogP: 2.68 | #Rotatable Bonds: 9 |
Polar Surface Area: 73.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.05 | CX LogP: 2.19 | CX LogD: 2.19 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.62 | Np Likeness Score: -1.20 |
1. OBATA T, FUJII K, FUNAKI E, TSUTSUMIUTI K, OHOKA A, SUIZU S, KANETSUKI Y. (1999) Synthesis and Selective Bioactivity of New Pyrazolecarboxamide Derivatives, 24 (1): [10.1584/jpestics.24.33] |
Source(1):